[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100139209":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":13,"locations":19,"responsibleParty":75,"collaborators":10,"id":78,"slug":79,"hasResults":80,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":84,"eligibilityCriteria":85,"healthyVolunteers":80,"sex":86,"minAge":87,"maxAge":88,"enrollmentInfo":89,"targetDuration":10,"studyType":92,"phases":10,"briefSummary":93,"conditions":94,"keywords":97,"overallStatus":99,"whyStopped":10,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":108},{"fullName":5,"class":6},"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","OTHER",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"the group of Jiangzhuo Qinggan prescription",null,{"label":12,"type":10,"description":10,"interventionNames":10},"the group of irbesartan",[14],{"name":15,"role":16,"phone":17,"phoneExt":10,"email":18},"Fenglian Li, PHD","CONTACT","0086-010-88001402","lfm565@sohu.com",[20,37,47,57,67],{"facility":21,"status":10,"city":22,"state":23,"zip":10,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"Beijing Medical University ,Dongzhimen Hospital","Beijing","Beijing Municipality","China","CN",{"type":27,"coordinates":28},"Point",[29,30],116.39723,39.9075,{"lat":30,"lon":29},[33],{"name":34,"role":16,"phone":35,"phoneExt":10,"email":36},"Weixing Lu","0086-013601067938","weixinglu918@sina.com",{"facility":38,"status":10,"city":22,"state":23,"zip":10,"country":24,"countryCode":25,"cosmosGeoPoint":39,"geoPoint":41,"contacts":42},"Beijing Medical University,Dongfang Hospital",{"type":27,"coordinates":40},[29,30],{"lat":30,"lon":29},[43],{"name":44,"role":16,"phone":45,"phoneExt":10,"email":46},"Qian Lin","0086-013910565673","dfluyao@126.com",{"facility":48,"status":10,"city":22,"state":23,"zip":10,"country":24,"countryCode":25,"cosmosGeoPoint":49,"geoPoint":51,"contacts":52},"China Academy of Chinese Medical Sciences,Guang'anmen Hospital",{"type":27,"coordinates":50},[29,30],{"lat":30,"lon":29},[53],{"name":54,"role":16,"phone":55,"phoneExt":10,"email":56},"Qiang Zhou","0086-015101016416","tiantianlanzhouqiang@126.com",{"facility":58,"status":10,"city":22,"state":23,"zip":10,"country":24,"countryCode":25,"cosmosGeoPoint":59,"geoPoint":61,"contacts":62},"Chinese Academy of Medical Sciences Fu Wai Cardiovascular Hospital",{"type":27,"coordinates":60},[29,30],{"lat":30,"lon":29},[63],{"name":64,"role":16,"phone":65,"phoneExt":10,"email":66},"Jianfeng Huang","0086-010-88396403","jianfhuang918@sina.com",{"facility":68,"status":10,"city":69,"state":23,"zip":10,"country":24,"countryCode":25,"cosmosGeoPoint":10,"geoPoint":10,"contacts":70},"Capital University of Medical, Anzhen Hospital","Beijng",[71],{"name":72,"role":16,"phone":73,"phoneExt":10,"email":74},"Zhenqiu Yu","0086-010-64456577","yuzhenqiu@yahoo.com.cn",{"type":10,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":76,"oldOrganization":77},"Guang'anmen Hospital","China Academy of Chinese Medical Sciences","100139209","jiangzhuo-qinggan-prescription-and-irbesartan-in-the-treatment-of-essential-hypertensionhepatogastric-damp-heatclinical-study-100139209",false,"NCT01082835","Jiangzhuo Qinggan Prescription and Irbesartan in the Treatment of Essential Hypertension(Hepatogastric Damp-heat)Clinical Study","Jiangzhuo Qinggan Prescription and Irbesartan in the Treatment of Essential Hypertension(Hepatogastric Damp-heat), Randomized, Parallel-controlled, Multi-center Clinical Study","JZQG","Inclusion Criteria:\n\n1. Consistent with diagnosed hypertension, blood pressure, for 1-2 grade.\n2. Aged 18-65 years old.\n3. Body mass index (BMI) ≥ 24kg\u002Fm2, but \\\u003C35 kg\u002Fm2.\n4. Waist circumference ≥ 85cm (male) or waist circumference ≥ 80cm (women).\n5. Comply with any of the following 3 : triglyceride (TG) elevated levels of:\\> 150mg\u002Fdl (1.7mmol \u002F l), or has received appropriate treatment; high-density lipoprotein - cholesterol (HDL-C) levels reduced: Men \\\u003C40mg\u002Fdl (0.9mmol \u002F l), women \\\u003C50mg\u002Fdl (1.1mmol \u002F l), or has received appropriate treatment; fasting plasma glucose (FPG) increased: FPG ≥ 100mg\u002Fdl (5.6mmol \u002F l ), or previously diagnosed type 2 diabetes or have received appropriate treatment.\n6. Hepatogastric Damp-heat syndrome differentiation.\n7. To sign informed consent.\n\nExclusion Criteria:\n\n1. Has been used to control lipids, blood sugar drugs, but use the time for those below the 1 month.\n2. Nearly 3 months, weight loss ≥ 5%.\n3. Suffering from congenital heart disease, rheumatic heart disease, congestive heart failure, unstable angina, and had a myocardial infarction, percutaneous transluminal coronary angioplasty (PTCA) or off-line clinical significance of arrhythmia.\n4. Bilateral renal artery stenosis, solitary kidney, serum creatinine\\> 133μmol \u002F L .\n5. Active liver disease, history of chronic persistent hepatitis, ALT\\> upper limit of normal.\n6. Peptic ulcer or malabsorption syndrome .\n7. With insulin-treated diabetes.\n8. There is a history of appetite or abuse of laxatives by hyperthyroidism.\n9. Pregnancy, pregnancy or breast-feeding women to prepare.\n10. For those who are allergic Chinese medicine, allergic people.\n11. Mentally ill.\n12. Hyperkalemia in patients.\n13. Cancer.\n14. Occurred within the past 6 months who had a stroke or transient ischemic attack (TIA).\n15. Nearly 3 months in patients receiving other clinical studies.\n16. Alcohol and \u002F or psychoactive substances, drug abuse and dependency.","ALL","18 Years","65 Years",{"count":90,"type":91},240,"ESTIMATED","OBSERVATIONAL","Jangzhuo Qinggan prescription and irbesartan in the treatment of essential hypertension(Hepatogastric Damp-heat), randomized, parallel-controlled, multi-center clinical study.",[95,96],"Hypertension","Metabolic Syndrome",[98],"Chinese herbs","UNKNOWN","2010-03-15",{"date":102,"type":91},"2010-03-16",{"date":104,"type":10},"2010-03",{"date":106,"type":91},"2010-08",{"name":5,"class":6},5]